Sharekhan

Aarti Pharmalabs Ltd

Fri 29/08/2025,15:59:30 NSE: AARTIPHARM

₹ 841.35 -4.60 (-0.54%)
BUY NOW Buy Aarti Pharmalabs Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Aarti Pharmalabs Ltd

Fri 29/08/2025,16:1:0

Aarti Pharmalabs Ltd

Fri 29/08/2025,15:59:30 | NSE : AARTIPHARM

₹ 841.35-4.60 (-0.54%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 843.80

Previous Close

₹ 845.95

Volume

184281

Mkt Cap ( Rs. Cr)

₹7626.10

High

₹ 853.50

Low

₹ 838.15

52 Week High

₹ 971.00

52 Week Low

₹ 557.05

Book Value Per Share

₹ 204.84

Dividend Yield

0.00

Face Value

₹ 5.00

What’s Your Call?

Collective community sentiment on Aarti Pharmalabs Ltd

Your Vote -

Buy

88.89%

Hold

0.00%

Sell

11.11%

88.89%

9 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

841.35

37

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

37

Option Chain

Analyzes market sentiment, predicts Aarti Pharmalabs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Aarti Pharmalabs - Reg. 34 (1) Annual Report.

    29 Aug 2025, 12:16PM Annual Report for FY 24-25.

  • Aarti Pharmalabs - General Updates

    29 Aug 2025, 12:11PM Aarti Pharmalabs Limited has informed the Exchange about General Updates

  • Aarti Pharmalabs - Business Responsibility and Sustainability Reporting (BRSR)

    29 Aug 2025, 12:03PM Please find attached BRSR for FY 24-25.

  • Aarti Pharmalabs - Shareholders meeting

    29 Aug 2025, 10:39AM Aarti Pharmalabs Limited has informed the Exchange regarding Notice of undefined to be held on September 22, 2025

  • Aarti Pharmalabs - Notice Of 6Th Annual General Meeting

    29 Aug 2025, 10:34AM Please find attached Notice of 6th Annual General Meeting along with Annual Report for FY 2024-25 of Aarti Pharmalabs Limited.

  • Aarti Pharmalabs has declared 50% Final dividend for the financial year March 2025

    22 Aug 2025, 11:47AM Aarti Pharmalabs Ltd. on Monday, 12 May 2025, has announced Final dividend of 50 percent on Equity Share, to its shareholders holding shares on the re

  • Aarti Pharmalabs - General Updates

    21 Aug 2025, 7:46PM Aarti Pharmalabs Limited has informed the Exchange about General Updates

  • Aarti Pharmalabs - Intimation Regarding 100 Days Campaign - ''Saksham Niveshak'

    21 Aug 2025, 7:41PM Please see attached for Intimation Regarding 100 days Campaign - \Saksham Niveshak\

  • Aarti Pharmalabs - Intimation Regarding 100 Days Campaign - ''Saksham Niveshak'

    21 Aug 2025, 7:41PM Please see attached for Intimation Regarding 100 days Campaign - \Saksham Niveshak\

  • Aarti Pharmalabs - Copy of Newspaper Publication

    20 Aug 2025, 1:56PM Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication

  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates

    20 Aug 2025, 1:46PM Aarti Pharmalabs Limited has informed the Exchange about Transcript

  • Aarti Pharmalabs - Intimation Regarding 100 Days Campaign - ''Saksham Niveshak'

    21 Aug 2025, 7:41PM Please see attached for Intimation Regarding 100 days Campaign - \Saksham Niveshak\

  • Aarti Pharmalabs - Intimation Regarding 100 Days Campaign - ''Saksham Niveshak'

    21 Aug 2025, 7:41PM Please see attached for Intimation Regarding 100 days Campaign - \Saksham Niveshak\

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    20 Aug 2025, 1:41PM Transcript for Q1 FY26 Earnings Conference Call

  • Aarti Pharmalabs - Record Date

    19 Aug 2025, 3:49PM Aarti Pharmalabs Limited has informed the Exchange that Record date for the purpose of DI is 15-Sep-2025.

  • Aarti Pharmalabs - Record Date For Final Dividend For FY 2024-25

    19 Aug 2025, 3:34PM Record Date for Dividend for FY 2024-25

  • Aarti Pharmalabs - Copy of Newspaper Publication

    14 Aug 2025, 4:02PM Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    13 Aug 2025, 6:34PM Recording of the Earnings Conference call for Q1 FY 26

  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Aug 2025, 6:25PM Aarti Pharmalabs Limited has informed the Exchange about Link of Recording

  • Aarti Pharmalabs - Investor Presentation

    13 Aug 2025, 12:55PM Aarti Pharmalabs Limited has informed the Exchange about Investor Presentation

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Investor Presentation

    13 Aug 2025, 12:47PM Investor Presentation for Q1 FY 26

  • Aarti Pharmalabs - ESOP/ESOS/ESPS

    12 Aug 2025, 8:14PM Aarti Pharmalabs Limited has informed the Exchange regarding Allotment of 6600 Shares.

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    12 Aug 2025, 8:02PM Please find enclosed.

  • Aarti Pharmalabs - Appointment

    12 Aug 2025, 7:51PM Aarti Pharmalabs Limited has informed the Exchange regarding Appointment of Mr as Other of the company w.e.f. August 12, 2025.

  • Aarti Pharmalabs - Appointment

    12 Aug 2025, 7:49PM Aarti Pharmalabs Limited has informed the Exchange regarding Appointment of Ms as Non- Executive Independent Director of the company w.e.f. August 12

  • Aarti Pharmalabs - Outcome of Board Meeting

    12 Aug 2025, 7:41PM Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Change in Management

    12 Aug 2025, 7:27PM Reappointment of Ms. Rupal Vora, Non-Executive Independent Director.

  • Aarti Pharmalabs - Financial Results For Quarter Ended June 30, 2025

    12 Aug 2025, 7:24PM Please find enclosed.

  • Aarti Pharmalabs - Appointment Of Secretarial Auditor

    12 Aug 2025, 7:17PM Please find enclosed.

  • Aarti Pharmalabs - Outcome of Board Meeting

    12 Aug 2025, 7:13PM Aarti Pharmalabs Limited has informed the Exchange regarding Board meeting held on August 12, 2025.

  • Aarti Pharmalabs - Board Meeting Outcome for Outcome Of Board Meeting For Approval Of Unaudited Financial Results With Limite

    12 Aug 2025, 7:11PM Please find enclosed.

  • Aarti Pharmalabs Q1 net profit up 8.66% at Rs 51.22 cr

    12 Aug 2025, 7:10PM The company reported standalone net profit of Rs 51.22 crore for the quarter ended June 30, 2025 as compared to Rs 47.14 crore in the same period last

  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates

    5 Aug 2025, 5:48PM Aarti Pharmalabs Limited has informed the Exchange about Schedule of meet

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    5 Aug 2025, 5:43PM This is to inform you that the Earnings Conference Call for Investors and Analysts, which would be a Group meet, has been scheduled on Wednesday, Augu

  • Aarti Pharmalabs - Board Meeting Intimation for Board Meeting Intimation For Unaudited Financial Results For The Quarter Ende

    1 Aug 2025, 12:14PM Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and

  • Aarti Pharmalabs has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    19 Jul 2025, 7:00AM As of June 2025, 43.72% is owned by Promoters and 56.28% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 43.55% and Forei

  • Aarti Pharmalabs - Credit Rating

    17 Jul 2025, 3:13PM Aarti Pharmalabs Limited has informed the Exchange about Credit Rating

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Credit Rating

    17 Jul 2025, 3:19PM Please find enclosed credit rating received from CRISIL Ratings Limited.

  • Aarti Pharmalabs - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Jul 2025, 12:19PM Aarti Pharmalabs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Aarti Pharmalabs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Jul 2025, 12:16PM Certificate for the quarter ended June 30, 2025.

  • Aarti Pharmalabs - Disclosure under SEBI Takeover Regulations

    3 Jul 2025, 11:01PM Chandrakant Vallabhaji Gogri has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (

  • Aarti Pharmalabs - Trading Window-XBRL

    25 Jun 2025, 4:59PM AARTI PHARMALABS LIMITED has informed the Exchange about Closure of Trading Window

  • Aarti Pharmalabs - Trading Window

    25 Jun 2025, 4:37PM Aarti Pharmalabs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,

  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates

    18 Jun 2025, 3:58PM Aarti Pharmalabs Limited has informed the Exchange about Schedule of meet

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    18 Jun 2025, 3:55PM Intimation of Earnings Conference Call
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Aarti Pharmalabs Ltd stock 

Name March-25 March-24 March-23 March-22
Assets 2238.7261 1872.2571 1645.2909 1608.9004
Liabilities 2238.7261 1872.2571 1645.2909 1608.9004
Equity 45.3173 45.313 45.313 45.563
Gross Profit 426.5432 346.1585 308.3352 179.7858
Net Profit 257.3488 200.6454 171.7268 106.7261
Cash From Operating Activities 340.0057 183.6944 228.6894 -64.8426
NPM(%) 14.52 13.35 11.36 11.34
Revenue 1771.3517 1502.1319 1511.2478 941.021
Expenses 1344.8085 1155.9734 1202.9126 761.2352
ROE(%) 13.86 10.8 9.24 5.74

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
15 Sep 2025 2.5 50 0 799.45
14 Feb 2025 2.5 50 0 636.3
31 Jul 2024 1 20 0 520.05
2 40 0 557.85

Peers

Other companies within the same industry or sector that are comparable to Aarti Pharmalabs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sharda Cropchem Ltd 949.10 1.51 20.39 7578.97 337.37 0.95
Amines and Plasticizers Ltd 220.92 0.89 30.56 4621.96 372.61 0.23
Indogulf Cropsciences Ltd 105.57 -1.13 0.00 1975.69 49.78 0.00
Grauer and Weil (India) Ltd 115.60 0.00 34.92 38088.87 346.70 0.43

Company Info

Our Company was incorporated as a public limited company under the Companies Act, 2013 in Gujarat, India pursuant to a certificate of incorporation dated November 22, 2019 issued by Registrar of Companies, Ahmedabad, Gujarat. The Corporate Identification Number (CIN) of the Company is U24100GJ2019PLC110964.Major events and milestone of our Company:2019Incorporation of the company. The Company had not commenced any business since its incorporation.2021The name of the Company was changed from `Aarti Organics Limited' to `Aarti Pharmalabs Limited'2022NCLT approved Scheme of Arrangement under the provisions of section 230 to 232 and other applicable provisions of the Companies Act, 2013 between Aarti Industries Limited and Aarti Pharmalabs Limited and their respective shareholders, sanctioned by the NCLT on September 21, 2022 (the certified true copy of the order was received on September 22, 2022). Pursuant to the Scheme, Pharma business of Aarti Industries Limited has been vested into the Company  2021 -Company name has changed to Aarti Pharmalabs Ltd. from Aarti Organics Ltd.

Our Company was incorporated as a public limited company under the Companies Act, 2013 in Gujarat, India pursuant to a certificate of incorporation dated November 22, 2019 issued by Registrar of Companies, Ahmedabad, Gujarat. The Corporate Identification Number (CIN) of the Company is U24100GJ2019PLC110964.Major events and milestone of our Company:2019Incorporation of the company. The Company had not commenced any business since its incorporation.2021The name of the Company was changed from `Aarti Organics Limited' to `Aarti Pharmalabs Limited'2022NCLT approved Scheme of Arrangement under the provisions of section 230 to 232 and other applicable provisions of the Companies Act, 2013 between Aarti Industries Limited and Aarti Pharmalabs Limited and their respective shareholders, sanctioned by the NCLT on September 21, 2022 (the certified true copy of the order was received on September 22, 2022). Pursuant to the Scheme, Pharma business of Aarti Industries Limited has been vested into the Company  2021 -Company name has changed to Aarti Pharmalabs Ltd. from Aarti Organics Ltd.

Read More

Parent Organisation

Aarti Pharmalabs Ltd.

Founded

22/11/2019

Managing Director

Mr.Narendra J Salvi

NSE Symbol

AARTIPHARMEQ

FAQ

The current price of Aarti Pharmalabs Ltd is ₹ 841.35.

The 52-week high for Aarti Pharmalabs Ltd is ₹ 853.50 and the 52-week low is ₹ 838.15.

The market capitalization of Aarti Pharmalabs Ltd is currently ₹ 7626.10. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Aarti Pharmalabs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Aarti Pharmalabs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Aarti Pharmalabs Ltd shares.

The CEO of Aarti Pharmalabs Ltd is Mr.Narendra J Salvi, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT